90733679 - MAB2

Information

• Trademark
• 90733679

• Source

• Serial Number

  90733679

• Registration Number

  7135330

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 25, 2021
  3 years ago

• Registration Date

  August 15, 2023
  a year ago

• Transaction Date

  October 31, 2024
  3 months ago

• Status Date

  August 15, 2023
  a year ago

• Published for Opposition Date

  May 30, 2023
  a year ago

• Location Date

  August 15, 2023
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  KEELEY, ALISON

• Attorney Docket Number

  66886-210508

  Attorney Name

  Shoko Naruo

  Law Office Assigned Location Code

  M40

• Owners

  • F-Star Biotechnology Limited

Case File Statements

• DM0000: The mark consists of the lower case letter "M" followed by an upper case letter "A" followed by a lower case letter "B" with a superscript "2" following the "B".
• GS0051: Pharmaceutical, biopharmaceutical and medical preparations, agents and substances, all containing or being monoclonal antibodies for medical purposes, and all for treatment of cancer, oncological diseases and disorders, infectious diseases and disorders, inflammation and diseases, disorders and conditions associated with inflammation, inflammatory diseases and disorders, and neurological diseases and disorders; bispecific and multispecific monoclonal antibodies for medical use; products in the nature of pharmaceutical preparations and medicines containing multispecific, in particular bispecific, monoclonal antibodies for use in medicine; diagnostic preparations, agents and substances, all containing or being monoclonal antibodies, for medical purposes
• PM0001: MAB TWO
• GS0011: Biological preparations containing monoclonal antibodies for scientific, industrial, and research use; bispecific and multispecific monoclonal antibodies, and fragments thereof, for scientific, industrial, and research use
• GS0421: Scientific and technological services, namely scientific research and design in the field of immunoglobulins and antibodies for medical purposes; scientific research, namely industrial analysis and research services, in the field of immunoglobulins and antibodies for medical purposes; pharmaceutical, scientific and biopharmaceutical research and development; medical research and development in the field of immunoglobulins and antibodies for medical purposes; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines; all of the foregoing involving monoclonal antibodies

Case File Event Statements

• 5/28/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 8/20/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/7/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/8/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/8/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/8/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/19/2022 - 2 years ago

  7 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 7/28/2022 - 2 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/28/2022 - 2 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/28/2022 - 2 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/16/2022 - 2 years ago

  11 - ASSIGNED TO EXAMINER Type: DOCK

• 9/20/2022 - 2 years ago

  12 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/20/2022 - 2 years ago

  13 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/20/2022 - 2 years ago

  14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/20/2023 - a year ago

  15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/20/2023 - a year ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/21/2023 - a year ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/27/2023 - a year ago

  18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/27/2023 - a year ago

  19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/27/2023 - a year ago

  20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/27/2023 - a year ago

  21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/27/2023 - a year ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/10/2023 - a year ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/30/2023 - a year ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/30/2023 - a year ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/15/2023 - a year ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/15/2023 - a year ago

  27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 10/30/2024 - 3 months ago

  28 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN